Practice-Changing Studies Presented at ASCO GI 2023

By Oncology Brothers - Last Updated: August 23, 2023

Rohit Gosain, MD, and Rahul Gosain, MD, known as the Oncology Brothers, talk highlights from ASCO GI 2023 with Mark Lewis, MD, a cancer survivor and director of gastrointestinal oncology at Intermountain Healthcare. Some of the studies covered include:

  • The SPOTLIGHT analysis of zolbetuximab plus mFOLFOX6
  • The randomized, phase III NAPOLI3 study, which assessed different treatment combinations in patients with metastatic pancreatic ductal adenocarcinoma
  • The SUNLIGHT analysis of trifluridine/tipiracil plus bevacizumab for refractory metastatic colorectal cancer

 

Post Tags:GI Onc Now VideosGI Oncology
Advertisement
Advertisement
Latest News

December 6, 2023